Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

EQL Pharma

55.00 SEK

-1.43 %

Less than 1K followers

EQL

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for EQL Pharma

P/E

Median 2019-2025

EV/S

Median 2019-2025

EV/EBIT

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)12.0513.4035.1031.0037.4042.3071.00
Shares29.129.129.129.129.129.129.1
Market cap350.2389.41,020.1901.01,087.01,229.42,063.5
Enterprise value328.5379.3994.9859.81,109.21,329.02,432.7
EV/S6.65.35.62.14.35.06.5
EV/EBITDA97.452.086.922.126.840.736.1
EV/EBITneg.120.286.922.126.840.736.1
P/Eneg.143.998.228.434.354.248.0
P/B4.484.8111.177.297.026.929.34
P/S7.05.45.72.24.24.75.5
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio76.6 %65.1 %45.9 %52.0 %54.2 %47.6 %27.3 %
Gearing ratio----43.1 %67.6 %204.3 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.